Benevolent Platform

benevolent.com · checked 14 Nov 2026

#13 · AI Drug Discovery Software

Visit benevolent.com ↗ Alternatives Benevolent Platform vs AlgoraeOS

How it plugs in

—Public API

NoOpen source

NoFree tier

Signal on AI Drug Discovery Software4.6#13 of 33

Near it

All alternatives →

Runs on

Web
Windows
Mac
Linux
iOS
Android

Facts

Website: benevolent.com
Price: Not published
Free trial: Not stated
AI and data: BenevolentAI describes its technology as using multimodal data to surface insights and accelerate biomedical discovery.
Collaborations: The company names AstraZeneca and Merck among its pharmaceutical discovery collaboration partners.
Contact: The company provides a press contact email address.
Drug discovery: The company says it uses its platform, scientific expertise, and wet-lab facilities to accelerate novel drug discovery.
Focus: In April 2024, BenevolentAI said it would focus on drug discovery collaborations and its proprietary pipeline.
Founded: BenevolentAI's press kit lists 2013 as its founding year.
Headquarters: The company describes itself as headquartered in London.
Knowledge Exploration Tools: The company announced that work on its Knowledge Exploration Tools would cease after a market assessment.
Knowledge graph: The company says its technology builds on investment in a knowledge graph and proprietary ontologies.
Platform development: A 2024 company announcement stated that investment would continue in development of the BenevolentAI Platform.
Platform offering: BenevolentAI describes its platform as integrating AI and science to uncover new biology, predict novel targets, and develop drugs for complex diseases.
Product availability: The current homepage presents Qor as an always-on strategic function for biopharma decision makers and life science consultancies.

On these boards

AI Drug Discovery Software#13 of 33

Built Benevolent Platform?

Claim the page, then edit your card yourself from your member desk: its name, words, logo, screenshots, plans and links. Your desk shows how many readers open it.

Claim Benevolent Platform